HPV-assoziierte Oropharynxkarzinome: Einschätzung des Erkrankungsrisikos

Zentrum für Krebsregisterdaten. Krebs in Deutschland für 2017/2018, 13. Ausgabe. Berlin: Robert Koch-Institut; 2021

S3-Leitlinie "Impfprävention HPV-assoziierter Neoplasien. AWMF-Registernr. 082-002; Stand Mai 2020

Jansen L et al. Mundhöhlen- und Pharynxkarzinome: Inzidenz, Mortalität und Überleben in Deutschland. Bundesgesundheitsbl. 2021; 64:941-50

Plummer M et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4:e609-16

Gillison ML et al. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. J Clin Oncol. 2015;33:3235-42

Tota JE et al. Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies. Prev Med. 2011; 53(Suppl 1):S12-21

Senkomago V et al. Human Papillomavirus-Attributable Cancers — United States, 2012-2016. MMWR Morb Mortal Wkly Rep. 2019;68:724-8

Vlachea P. Etablierung eines RT-PCR-Assays zum Nachweis von E6/E7-Onkogen-Transkripten aus archiviertem Paraffingewebe von Plattenepithelkarzinomen der Kopf-Hals-Region [dissertation]. München: LMU; 2021

Buttmann-Schweiger N et al. Cancer incidence in Germany attributable to human papillomavirus in 2013. BMC Cancer. 2017;17:682

Stanley M. Perspective: Vaccinate boys too. Nature. 2012;488:S10

Stein AP et al. Prevalence of Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma in the United States Across Time. Chem Res Toxicol. 2014;27:462-9

Ndiaye C et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15:1319-31

Mehanna H et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck, vol. 35, no. 5, pp. 747-755, May 2013, doi: 10.1002/hed.22015.

Rettig E et al. The role of sexual behavior in head and neck cancer: implications for prevention and therapy. Expert Rev Anticancer Ther. 2015;15:35-49

Van Dyne EA et al. Trends in Human Papillomavirus-Associated Cancers — United States, 1999-2015. MMWR Morb Mortal Wkly Rep. 2018;67:918-24

Tota JE et al. Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals. J Clin Oncol. 2019;37:1538-46

Chaturvedi AK et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294-301

Braakhuis BJM et al. Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol. 2014;50:670-5

Prigge ES et al. p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region. Int J Cancer. 2015;136:1589-99

Wittekindt C et al. Oropharynxkarzinome: Wenn humane Papillomviren die Tumorauslöser sind. Dtsch Arztebl. 2018;115:[10]

Smith EM et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer. 2004;108:766-72

Kreimer AR et al. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis. 2010;37:386-91

Beachler DC et al. Natural History of Anal vs Oral HPV Infection in HIV-Infected Men and Women. J Infect Dis. 2013;208:330-9

Lang Kuhs KA et al. Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis. Cancer Epidemiol Biomarkers Prev. 2015;24:683-9

Steinau M et al. Prevalence of Cervical and Oral Human Papillomavirus Infections Among US Women. J Infect Dis. 2014;209:1739-43

Kreimer AR et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet. 2013;382:877-87

Wittekindt C et al. HPV - Das andere Kopf-Hals-Karzinom. Laryngo-Rhino-Otologie. 2018;97:S48-S81

Chesson HW et al. The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States. Sex Transm Dis. 2014;41:660-4

D'Souza G et al. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer. Ann Oncol. 2017;28:3065-9

Kero K et al. Smoking increases oral HPV persistence among men: 7-year follow-up study. Eur J Clin Microbiol Infect Dis. 2014;33:123-33

Rautava J et al. Prevalence, Genotype Distribution and Persistence of Human Papillomavirus in Oral Mucosa of Women: A Six-Year Follow-Up Study. PLoS One. 2012;7,:e42171

Gillison ML et al. Prevalence of Oral HPV Infection in the United States, 2009-2010. JAMA. 2012;307:693-703

Chaturvedi AK et al. Incidence Trends for Human Papillomavirus-Related and -Unrelated Oral Squamous Cell Carcinomas in the United States. J Clin Oncol. 2008;26:612-9

Herrero R et al. Human Papillomavirus and Oral Cancer: The International Agency for Research on Cancer Multicenter Study. J Natl Cancer Inst. 2003;95:1772-83

Drake VE et al. Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer. Cancer. 2021;127:1029-38

D'Souza G et al. Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer. N Engl J Med. 2007;356:1944-56

Farsi NJ et al. Sexual behaviours and head and neck cancer: A systematic review and meta-analysis. Cancer Epidemiol. 2015;39:1036-46

Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005;32:16-24

Heck JE et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol. 2010;39:166-81

Gillison ML et al. Distinct Risk Factor Profiles for Human Papillomavirus Type 16-Positive and Human Papillomavirus Type 16-Negative Head and Neck Cancers.," J natl Cancer Inst. 2008;100:407-20

Manhart LE, Koutsky LA. Do Condoms Prevent Genital HPV Infection, External Genital Warts, or Cervical Neoplasia? Sex Transm Dis. 2002;29:725-35

Nielson CM et al. Consistent Condom Use Is Associated with Lower Prevalence of Human Papillomavirus Infection in Men. J Infect Dis. 2010;202:445-51

Kjaer SK et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev. 2001;10:101-6

Beachler DC et al. Risk Factors for Acquisition and Clearance of Oral Human Papillomavirus Infection Among HIV-Infected and HIV-Uninfected Adults Am J Epidemiol. 2015;181:40-53

Giuliano AR et al. EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer. 2015;136:2752-60

D'Souza G, Dempsey A. The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med. 2011;53(Suppl 1):S5-S11

Safaeian M et al. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections. J Natl Cancer Inst. 2010;102:1653-62

Ho GYF et al. Risk Factors for Subsequent Cervicovaginal Human Papillomavirus (HPV) Infection and the Protective Role of Antibodies to HPV-16 Virus-Like Particles. J Infect Dis. 2002;186:737-42

Herrero R et al. Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica. PLoS One. 2013;8:e68329

Kreimer AR et al. Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer. J Clin Oncol. 2013;31:2708-15

Lu B et al. Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in Men. Cancer Res. 2021;72:676-85

D'Souza G et al. Oral Human Papillomavirus (HPV) Infection in HPV-Positive Patients With Oropharyngeal Cancer and Their Partners. J Clin Oncol. 2014;32:2408-15

Vogt SL et al. Concordant Oral-Genital HPV Infection in South Africa Couples: Evidence for Transmission. Front. Oncol. 2013;3:303

Rintala M et al. Natural history of oral papillomavirus infections in spouses: A prospective Finnish HPV Family Study. J Clin Virol. 2006;35:89-94

Mirghani H et al. Is there an increased risk of cancer among spouses of patients with an HPV-related cancer: A systematic review. Oral Oncol. 2017;67:138-45

Szymonowicz KA, Chen J. Biological and clinical aspects of HPV-related cancers. Cancer Biol Med. 2020;17:864-78

Gillison ML et al. Human Papillomavirus and Diseases of the Upper Airway: Head and Neck Cancer and Respiratory Papillomatosis. Vaccine. 2021;30(Supp 5):F34-54

Chi AC et al. Oral cavity and oropharyngeal squamous cell carcinoma-an update. CA Cancer J Clin. 2015;65:401-21

Elrefaey S et al. HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital. 2014;34:299-309

Evans M et al. Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population. BMC Cancer. 2013;13:220

Berman TA, Schiller JT. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Cancer. 2017;123:2219-29